Scd1 localization at the cell ends is reduced upon inhibition of the Arp2/3 complex. (A) Localization of Scd1-mNG, Scd2-GFP, and Rga4-GFP at the ends of DMSO and CK-666-treated cells. Asterisks mark the site of Scd1-mNG and Scd2-GFP localization at the cell ends. Brackets label Rga4-GFP along the cell sides. (B and C) Quantification of Scd1-mNG and Scd2-GFP intensities at ends of DMSO and CK-666-treated cells (N = 3, n ≥ 10 cells). Scale bar, 10 μm. n.s., not significant; P value, *<0.05, Student’s t test.